A Novel Six Consecutive Monthly Doses of Palivizumab Prophylaxis Protocol for the Prevention of Respiratory Syncytial Virus Infection in High-Risk Preterm Infants in Taiwan

BACKGROUND: Respiratory syncytial virus (RSV) circulates year round in Taiwan. A novel six consecutive monthly doses of palivizumab for RSV prevention protocol has been approved for high risk preterm infants since December 2010. This study aimed to determine the clinical effectiveness and safety of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Chi, Hsin, Hsu, Chyong-Hsin, Chang, Jui-Hsing, Chiu, Nan-Chang, Hung, Han-Yang, Kao, Hsin-An, Weng, Li-Chuan, Huang, Fu-Yuan, Chiu, Yu-Ying, Chang, Luan-Yin, Huang, Li-Min
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2014
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4074126/
https://ncbi.nlm.nih.gov/pubmed/24971565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0100981
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares